News

NRX

IPO Report: NephroGenex (NRX)

Francis Gaskins | Equities.com |

NephroGenex ($NRX) is a pharmaceutical company focused on the development of therapeutics to treat kidney disease, an area of significant unmet medical need. 13 other companies are scheduled to


12 IPOs Planned for February 3 Week

Francis Gaskins | Equities.com |

The full IPO calendar is available at IPOpremium.com Ranked by size of IPO, largest first. (1) Real estate finance Based in New York, NY, Ladder Capital ($LADR) scheduled a $225 million IPO on the


Zuckerberg Launches Silicon Valley PAC, While Facebook Strengthens Its Mobile Advertising

Michael Teague | Equities.com |

Last week was a busy, high-profile one for Facebook (FB). The company introduced its one billion-plus users to “Facebook Home” last Thursday, a sort of mobile operating system within Google's


Sponsored Financial Content

Market Movers